Source: Annual Congress 2004 - Biological correlates of COPD
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
J. Musil, P. Cáp, F. Pehal (Prague, Czech Republic). Can we use the evaluation of leukotriens in breath condensate for the diagnosis of chronic obstructive pulmonary disease (COPD)?. Eur Respir J 2004; 24: Suppl. 48, 499

Member's Comments

No comment yet.

Related content which might interest you: Reproducibility of exhaled breath condensate pH in chronic obstructive pulmonary disease Source: Eur Respir J 2005; 25: 269-274 Year: 2005 Early phenotypes of chronic obstructive pulmonary disease (COPD) Source: International Congress 2015 – Different data in COPD Year: 2015 Underutilization of spirometry in the hospital diagnosis of chronic obstructive pulmonary disease (COPD) Source: Annual Congress 2008 - Organisation of care and management of COPD Year: 2008 Myeloperoxidase in exhaled breath condensate reflects the status of lung parenchyma during the exacerbation of chronic obstructive pulmonary disease Source: Eur Respir J 2005; 26: Suppl. 49, 54s Year: 2005 The relationships between markers of inflammation in exhaled breath condensate and bronchoalveolar lavage in patients with chronic obstructive pulmonary disease (COPD) Source: Eur Respir J 2004; 24: Suppl. 48, 307s Year: 2004 Improvement of diagnosis and treatment of obstructive lung diseases with a one stop diagnostic consultancy Source: Annual Congress 2006 - COPD – the challenges for primary care Year: 2006 Use of spirometry screening for patients with chronic obstructive pulmonary disease (COPD) requiring oxygen therapy Source: Eur Respir J 2006; 28: Suppl. 50, 838s Year: 2006 Potential biomarkers in patients with chronic obstructive pulmonary disease (COPD) Source: Virtual Congress 2020 – Mechanistic insight into lung injury and repair Year: 2020 The evaluation of a helpline for chronic obstructive pulmonary disease (COPD) Source: Annual Congress 2004 - Smoking and cessation in respiratory disease Year: 2004 Chronic obstructive pulmonary disease (COPD) patients with bronchiectasis: clinical features? Source: International Congress 2018 – COPD exacerbations and bronchiectasis Year: 2018 Optimal assessment and management of chronic obstructive pulmonary disease (COPD) Source: Guideline 1995 Year: 1995 Detection of asthma and chronic obstructive pulmonary disease in primary care Source: Eur Respir J 2003; 21: 16S-22S Year: 2003 The role smoking in development of dust-indusde chronic obstructive pulmonary disease (COPD) Source: Eur Respir J 2004; 24: Suppl. 48, 608s Year: 2004 Frequency of osteoporosis and pulmonary diffusing capacity in patients with chronic obstructive pulmonary disease (COPD) Source: International Congress 2014 – COPD: points to ponder Year: 2014 The impact of using different symptom-based exacerbation algorithms in patients with COPD Source: Eur Respir J 2011; 37: 1260-1268 Year: 2011 Spirometry to detect and manage chronic obstructive pulmonary disease and asthma in the primary care setting Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-36-7, page=1 Year: 2005 Application of impulse oscillometry and bronchial dilation test for analysis in patients with asthma and chronic obstructive pulmonary disease Source: International Congress 2016 – Notable abstracts on clinical problems related to asthma Year: 2016 Definition and differential diagnosis of chronic obstructive pulmonary disease Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-48-0, page=1 Year: 2006 Who are they? Characteristics of smokers with previously undetected COPD Source: Annual Congress 2006 - COPD – the challenges for primary care Year: 2006 Therapeutic approaches in the chronic obstructive (COPD) pulmonary disease Source: Eur Respir J 2002; 20: Suppl. 38, 472s Year: 2002